Skip to main content

Table 4 Mean physical component summary scores reported at each visit by participant group

From: Health-related quality of life and tuberculosis: a longitudinal cohort study

Visit

Crude estimate

Adjusted estimate a

95% Confidence interval adjusted estimate

P-value*

Baseline

    

Tuberculosis disease

49.5

50.0

49.5 - 50.5

0.001*

Latent tuberculosis infection

50.3

50.6

50.3 - 51.0

0.37

Controlb

50.2

50.7

50.1 - 51.2

-

1 month of treatment

   

Tuberculosis disease

49.5

49.9

49.4 - 50.5

0.90

Latent tuberculosis infection

50.2

50.5

50.1 - 50.9

0.98

Control

50.2

50.7

50.1 - 51.3

-

2 months of treatment

   

Tuberculosis disease

49.5

50.0

49.4 - 50.5

0.45

Latent tuberculosis infection

50.3

50.6

50.2 - 51.0

0.95

Control

50.2

50.8

50.3 - 51.3

-

4 months of treatment

   

Tuberculosis disease

50.0

50.4

49.8 - 51.0

0.89

Latent tuberculosis infection

50.1

50.4

50.0 - 50.8

0.90

Control

50.1

50.8

50.2 - 51.5

-

6 months of treatment

   

Tuberculosis disease

49.7

50.2

49.7 - 50.7

0.89

Latent tuberculosis infection

50.1

50.5

50.0 - 50.9

0.96

Control

50.1

50.8

50.3 - 51.4

-

9 months of treatment

   

Tuberculosis disease

49.6

49.9

49.3 - 50.5

0.09

Latent tuberculosis infection

50.3

50.6

50.2 - 51.1

0.90

Control

50.1

51.1

50.5 - 51.8

-

12 months of treatment

   

Tuberculosis disease

49.6

50.1

49.5 - 50.6

0.04*

Latent tuberculosis infection

50.2

50.6

50.1 - 51.0

0.50

Control

50.0

50.7

50.1 - 51.3

-

  1. aAdjusted models comparing participants treated for tuberculosis disease to those participants in the untreated control group controlled for age at baseline, sex, other medication exposures at baseline (yes/no) reported in medical charts, and number of individuals residing in participants’ households. Adjusted models comparing participants treated for latent tuberculosis infection to those participants in the untreated control group controlled for age at baseline and sex.
  2. bControl is a participant screened for tuberculosis who tested negative for tuberculosis and was found not to require treatment.
  3. *Indicates a p-value less than 0.05 meaning a statistically significant difference in mean physical component summary scores reported by the group of treated participants and the participants in the control group in the adjusted model, at the given visit.